Effectiveness of benzyl benzoate treatment on clinical symptoms and Demodex density over time in patients with rosacea and demodicosis: a real life retrospective follow-up study comparing low- and high-dose regimens

References

• Berg M, Lidén S. An epidemiological study of rosacea. Acta Derm Venereol (Stockh). 1989;69(5):419–423.
   PubMed Web of Science ®Google Scholar
• Wilkin J, Dahl M, Detmar M, et al. Standard classification of rosacea: report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J Am Acad Dermatol. 2002;46(4):584–587.
   PubMed Web of Science ®Google Scholar
• Forton F, Germaux MA, Brasseur T, et al. Demodicosis and rosacea: epidemiology and significance in daily dermatological practice. J Am Acad Dermatol. 2005;52(1):74–87.
   PubMed Web of Science ®Google Scholar
• Chen WC, Plewig G. Are Demodex mites principal, conspirator, accomplice, witness or bystander in the cause of rosacea? Am J Clin Dermatol. 2015;16(2):67–72.
   PubMed Web of Science ®Google Scholar
• Tan J, Almeida L, Bewley A, et al. Updating the diagnosis, classification and assessment of rosacea: recommendations from the global ROSacea COnsensus (ROSCO) panel. Br J Dermatol. 2017;176(2):431–438.
   PubMed Web of Science ®Google Scholar
• Forton F, Seys B. Density of Demodex folliculorum in rosacea: a case control study using standardized skin surface biopsy. Br J Dermatol. 1993;128(6):650–659.
   PubMed Web of Science ®Google Scholar
• Bonnar E, Eustace P, Powell FC. The Demodex mite population in rosacea. J Am Acad Dermatol. 1993;28(3):443–448.
   PubMed Web of Science ®Google Scholar
• Erbagci Z, Ozgoztasi O. The significance of Demodex folliculorum density in rosacea. Int J Dermatol. 1998;37(6):421–425.
   PubMed Web of Science ®Google Scholar
• Georgala S, Katoulis AC, Kylafis GD, et al. Increased density of Demodex folliculorum and evidence of delayed hypersensitivity reaction in subjects with papulopustular rosacea. J Eur Acad Dermatol Venerol. 2001;15(5):441–444.
   PubMed Web of Science ®Google Scholar
• Ya Z, Wu LP, Peng Y, et al. Retrospective analysis of the association between Demodex infestation and rosacea. Arch Dermatol. 2010;146(8):896–902.
   PubMedGoogle Scholar
• Sattler EC, Maier T, Hoffmann VS, et al. Non-invasive in vivo detection and quantification of Demodex mites by confocal laser scanning microscopy. Br J Dermatol. 2012;167(5):1042–1047.
   PubMed Web of Science ®Google Scholar
• Forton F, Maertelaer V. Two consecutive standardized skin surface biopsies: an improved sampling method to evaluate Demodex density as a diagnostic tool for rosacea and demodicosis. Acta Derm Venerol. 2017;97(2):242–248.
   PubMed Web of Science ®Google Scholar
• Casas C, Paul C, Lahfa M, et al. Quantification of Demodex folliculorum by PCR in rosacea and its relationship to skin innate immune activation. Exp Dermatol. 2012;21(12):906–910.
   PubMed Web of Science ®Google Scholar
• Forton F. Demodex et inflammation périfolliculaire chez l’homme: revue et observation de 69 biopsies. [Demodex and perifollicular inflammation in man: review and report of 69 biopsies]. Ann Dermatol Vénéréol. 1986;113(11):1047–1058.
   PubMed Web of Science ®Google Scholar
• Akilov OE, Mumcuoglu KY. Immune response in demodicosis. J Eur Acad Dermatol Venereol. 2004;18(4):440–444.
   PubMed Web of Science ®Google Scholar
• Forton F. Papulopustular rosacea, skin immunity and Demodex: pityriasis folliculorum as a missing link. J Eur Acad Dermatol Venereol. 2012;26(1):19–28.
   PubMed Web of Science ®Google Scholar
• Lacey N, Russell-Hallinan A, Zouboulis CC, et al. Demodex mites modulate sebocyte immune reaction: possible role in the pathogenesis of rosacea. Br J Dermatol. 2018;179(2):420–430.
   PubMed Web of Science ®Google Scholar
• Stein Gold LS, Kircik L, Fowler J, et al. Efficacy and safety of ivermectin 1% cream in treatment of papulopustular rosacea: results of two randomized, double-blind, vehicle-controlled pivotal studies. J Drugs Dermatol. 2014;13(3):316–323.
   PubMed Web of Science ®Google Scholar
• Taieb A, Ortonne JP, Ruzicka T, et al. Superiority of ivermectin 1% cream over metronidazole 0.75% cream in treating inflammatory lesions of rosacea: a randomized, investigator-blinded trial. Br J Dermatol. 2015;172(4):1103–1110.
   PubMed Web of Science ®Google Scholar
• Schaller M, Schöfer H, Homey B, et al. Rosacea management: update on general measures and topical treatment options. J Dtsch Dermatol Ges. 2016;14(Suppl. 6):17–27.
   Google Scholar
• Siddiqui K, Stein Gold L, Gill J. The efficacy, safety, and tolerability of ivermectin compared with current topical treatments for the inflammatory lesions of rosacea: a network meta-analysis. SpringerPlus. 2016;5(1):1151.
   PubMedGoogle Scholar
• Schaller M, Gonser L, Belge K, et al. Dual anti-inflammatory and anti-parasitic action of topical ivermectin 1% in papulopustular rosacea. J Eur Acad Dermatol Venereol. 2017;31(11):1907–1911.
   PubMed Web of Science ®Google Scholar
• Ebbelaar CCF, Venema AW, Van Dijk MR. Topical ivermectin in the treatment of papulopustular rosacea: a systematic review of evidence and clinical guideline recommendations. Dermatol Ther (Heidelb). 2018;8(3):379–387.
   PubMed Web of Science ®Google Scholar
• Bikowski JB, Del Rosso JQ. Demodex dermatitis: a retrospective analysis of clinical diagnosis and successful treatment with topical crotamiton. J Clin Aesthet Dermatol. 2009;2(1):20–25.
   PubMedGoogle Scholar
• Harmelin Y, Delaunay P, Erfan N, et al. Interest of confocal laser scanning microscopy for the diagnosis and treatment monitoring of demodicosis. J Eur Acad Dermatol Venereol. 2014;28(2):255–257.
   PubMed Web of Science ®Google Scholar
• Forton FMN, De Maertelaer V. Treatment of rosacea and demodicosis with benzyl benzoate: effects of different doses on Demodex density and clinical symptoms. J Eur Acad Dermatol Venereol. 2020;34(2):365–369.
   PubMed Web of Science ®Google Scholar
• Forton F, Seys B, Marchal JL, et al. Demodex folliculorum and topical treatments: acaricide action evaluated by standardized skin-surface biopsy. Br J Dermatol. 1998;138(3):461–466.
   PubMed Web of Science ®Google Scholar
• Wishart DS, Feunang YD, Guo AC, et al. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 2018;46(D1):D1074–D1082.
   PubMed Web of Science ®Google Scholar
• Akdeniz S, Bahceci M, Tuzcu AK, et al. Is Demodex folliculorum larger in diabetic patients? J Eur Acad Dermatol Venereol. 2002;16(5):539–541.
   PubMed Web of Science ®Google Scholar
• Aydingöz IE, Mansur T, Dervent B. Demodex folliculorum in renal transplant patients. Dermatology. 1997;195(3):232–234.
   PubMed Web of Science ®Google Scholar
• Turgut Erdemir A, Gurel MS, Koku Aksu AE, et al. Reflectance confocal microscopy vs. standardized skin surface biopsy for measuring the density of Demodex mites. Skin Res Technol. 2014;20(4):435–439.
   PubMed Web of Science ®Google Scholar
• Karincaoglu Y, Esrefoglu Seyhan M, Bayram N, et al. Incidence of Demodex folliculorum in patients with end stage chronic renal failure. Ren Fail. 2005;27(5):495–499.
   PubMed Web of Science ®Google Scholar
• Lazaridou E, Apalla Z, Sotiraki S, et al. Clinical and laboratory study of rosacea in northern Greece. J Eur Acad Dermatol Venereol. 2010;24(4):410–414.
   PubMed Web of Science ®Google Scholar
• Aşkin U, Seçkin D. Comparison of the two techniques for measurement of the density of Demodex folliculorum: standardized skin surface biopsy and direct microscopic examination. Br J Dermatol. 2010;162(5):1124–1126.
   PubMed Web of Science ®Google Scholar
• Salem DA, El-Shazly A, Nabih N, et al. Evaluation of the efficacy of oral ivermectin in comparison with ivermectin-metronidazole combined therapy in the treatment of ocular and skin lesions of Demodex folliculorum. Int J Infect Dis. 2013;17(5):e343–e347.
   PubMed Web of Science ®Google Scholar
• Murillo N, Aubert J, Raoult D. Microbiota of Demodex mites from rosacea patients and controls. Microb Pathog. 2014;71–72:37–40.
   PubMed Web of Science ®Google Scholar
• Helm KF, Menz J, Gibson LE, et al. A clinical and histopathologic study of granulomatous rosacea. J Am Acad Dermatol. 1991;25(6 Pt 1):1038–1043.
   PubMed Web of Science ®Google Scholar
• Aroni K, Tsagroni E, Lazaris AC, et al. Rosacea: a clinicopathological approach. Dermatology (Basel). 2004;209(3):177–182.
   PubMed Web of Science ®Google Scholar
• Thyssen JP. Are Demodex mites the best target for rosacea treatments? Br J Dermatol. 2019;181(4):652–653.
   PubMed Web of Science ®Google Scholar
• Del Rosso JQ, Tanghetti E, Webster G, et al. Update on the management of rosacea from the American Acne & Rosacea Society (AARS). J Clin Aesthet Dermatol. 2019;12(6):17–24.
   PubMedGoogle Scholar
• Ali ST, Alinia H, Feldman SR. The treatment of rosacea with topical ivermectin. Drugs Today. 2015;51(4):243.doi:https://doi.org/10.1358/dot.2015.51.4.2318439.
   PubMed Web of Science ®Google Scholar
• Abokwidir M, Fleischer A B. Additional evidence that rosacea pathogenesis may involve demodex: new information from the topical efficacy of ivermectin and praziquantel. Dermatol Online J. 2015;21(9).
   PubMedGoogle Scholar
• Logger J G M, Peppelman M, Van Erp P E J, et al. Value of reflectance confocal microscopy for the monitoring of rosacea during treatment with topical ivermectin. The Journal of Dermatological Treatment. J Dermatolog Treat. 2020:1–9. doi:https://doi.org/10.1080/09546634.2020.1741501.
   Google Scholar
• Trave I, Merlo G, Cozzani E, et al. Real-life experience on effectiveness and tolerability of topical ivermectin in papulopustular rosacea and antiparasitic effect on Demodex mites. Dermatol Ther. 2019;32:e13093. doi: https://doi.org/10.1111/dth.13093
   Google Scholar
• Wilkin J, Dahl M, Detmar M, et al. Standard grading system for rosacea: report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J Am Acad Dermatol. 2004;50(6):907–912.
   PubMed Web of Science ®Google Scholar